1Chiti A,Fanti D, Savelli G,et al. Comparison of somatostatin receptor imaging,computed tomography and ultrasound in the clinical management of neuroendocrine gatroenteropancreatic tumours.Eur J Nucl Med,1998,25:1396-1403.
2Hellman P,Andersson M,Rastad J,et al. Surgical strategy for large or malignant endocrine pancreatic tumours. World J Surg,2000,24:1353-1360.
3Grant CS. Surgical management of malignant islet cell tumours. World J Surg,1993,17:498-503.
4Cheslym-Curtis S,Sitaram V, Williamson RCN. Management of nonfunctional neuroendocrine tumours of the pancreas. Br J Surg,1993,80:625-627.
5R?sch T, Lightdale CJ, Botet JF,et al. Localization of pancreatic endocrine tumours by endoscopic endoscopic ultrasonography . N Engl J Med,1992,326:1721-1726.
7Que FG, Nagorney DM, Batts KP, et al, Hepatic resection of metastatic endocrine carcinomas. Am J Surg,1995,169:36.
8李继光，中华消化杂志，1998年，18卷，21页
9Peck AB, Cornelius JG, Chaudhari N. Use of in vitro-generated stem cell derived islets to cure type I diabetes: how close are we? Ann N Y Acad Sci, 2002,958:59-68.
10Docherty K. Growth and development of the islets of Langerhans: implication for the treatment of diabetes mellitus. Curr Opin Pharmacol, 2001,1:641-650.
